Lemaitre Vascular Inc (LMAT)

Precedente Chiudi:

$66.77

Aprire:

$72

Volume 24 ore:

328.69K

Capitalizzazione di mercato:

$1.67B

Reddito:

$193.48M

Utile/perdita netta:

$30.11M

Rapporto P/E:

61.34

EPS:

1.21

Flusso di cassa netto:

$29.49M

1 W Prestazione:

+13.38%

1M Prestazione:

+16.37%

6M Prestazione:

+53.06%

1 anno Prestazione:

+17.64%

Intervallo 1D:

$69.82

$74.45

Portata 52W:

$44.27

$74.64

Lemaitre Vascular Inc Stock (LMAT) Company Profile

Nome

Lemaitre Vascular Inc

Settore

Healthcare (1213)

Industria

Medical Instruments & Supplies (60)

Telefono

781-221-2266

Indirizzo

63 Second Avenue, Burlington, MA

Dipendente

400

Cinguettio

@LMAT_Vascular

Prossima data di guadagno

2024-05-31

Ultimi documenti SEC

LMAT's Discussions on Twitter

Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-06	Ripresa	KeyBanc Capital Markets	Sector Weight
2023-10-23	Iniziato	JMP Securities	Mkt Outperform
2023-09-06	Iniziato	Oppenheimer	Outperform
2023-08-03	Downgrade	Jefferies	Buy → Hold
2023-05-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-10-28	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-09-16	Iniziato	Jefferies	Buy
2021-02-12	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-03-16	Aggiornamento	Sidoti	Neutral → Buy
2019-10-24	Downgrade	First Analysis Sec	Strong Buy → Outperform
2019-10-24	Aggiornamento	Lake Street	Hold → Buy
2019-10-14	Aggiornamento	First Analysis Sec	Outperform → Strong Buy
2019-07-25	Reiterato	Barrington Research	Outperform
2019-07-25	Aggiornamento	First Analysis Sec	Neutral → Outperform
2018-10-08	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2018-10-08	Aggiornamento	ROTH Capital	Neutral → Buy
2018-06-08	Ripresa	ROTH Capital	Buy
2018-04-26	Downgrade	Stifel	Buy → Hold
2018-04-26	Aggiornamento	The Benchmark Company	Hold → Buy
2017-10-27	Downgrade	First Analysis Sec	Overweight → Equal-Weight
2017-10-27	Downgrade	The Benchmark Company	Buy → Hold
2017-07-10	Downgrade	Canaccord Genuity	Buy → Hold
2017-07-10	Downgrade	The Benchmark Company	Buy → Hold
2017-03-21	Iniziato	First Analysis Sec	Overweight
2017-02-22	Downgrade	Barrington Research	Outperform → Mkt Perform
2016-09-22	Downgrade	Sidoti	Buy → Neutral
2016-07-28	Reiterato	Barrington Research	Outperform
2016-02-25	Reiterato	Barrington Research	Outperform

Mostra tutto

Lemaitre Vascular Inc Borsa (LMAT) Ultime notizie

LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates

Zacks Investment Research

LeMaitre Q1 2024 Financial Results

GlobeNewswire Inc.

LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024

GlobeNewswire Inc.

AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management

Zacks Investment Research

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Zacks Investment Research

Here's Why You Should Hold BD (BDX) Stock in Your Portfolio

Zacks Investment Research

Lemaitre Vascular Inc Azioni (LMAT) Dati Finanziari

Lemaitre Vascular Inc (LMAT) Reddito 2024

Lemaitre Vascular Inc (LMAT) Reddito netto 2024

Lemaitre Vascular Inc (LMAT) Flusso di cassa 2024

Lemaitre Vascular Inc (LMAT) Utile per azione 2024

Lemaitre Vascular Inc Azioni (LMAT) insider trading